Form 4: Vertex Pharmaceuticals EVP Charles Wagner Jr. Reports Stock Disposal
SEC Form 4 Filing
Charles Wagner Jr., EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 2,293 shares of common stock on February 14, 2025, to cover tax obligations.
Summary
- On February 14, 2025, Charles F. Wagner Jr., the EVP & Chief Financial Officer of Vertex Pharmaceuticals, disposed of 2,293 shares of common stock.
- The transaction was executed at a price of $463.46 per share.
- Following the transaction, Wagner directly owns 63,241 shares of Vertex Pharmaceuticals common stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. This allows investors to track insider sentiment and potential alignment with company performance.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 02/14/2025 | Date of stock disposal transaction |
| 02/19/2025 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.